Prediction of treatment response using human leukocyte antigens considering sex differences, cancer family history, and association with peptides matching human endogenous retrovirus genes

Annals of Cancer Research and Therapy 2026 Open access

Read full text
Authors: Kyoji Ogoshi, Kunihiro Iwata, Seiichi Takenoshita
DOI: 10.4993/acrt.34.1
Cited by: 0
References: 22

Abstract

Introduction: Therapists must select the best treatment appropriate for the patient. We conducted clinical trials to identify potential human leukocyte antigens (HLAs) in response to cancer treatment.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses vaccines and immunoinformatics approaches

Publication details

Journal / source
Annals of Cancer Research and Therapy
Volume
34
Issue
1
Pages
1–14
Publication date
1 January 2026
Language
EN